Location History:
- Berkshire, GB (1999)
- Wokingham, GB (1996 - 2000)
Company Filing History:
Years Active: 1996-2000
Title: Innovations of David Charles Holt
Introduction
David Charles Holt is a notable inventor based in Wokingham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of plant-derived enzymes and DNA sequences. With a total of three patents to his name, Holt's work has implications for agricultural advancements and transgenic plant development.
Latest Patents
Holt's latest patents include innovative methods involving the chemically-inducible 27 kD subunit of the enzyme glutathione-S-transferase, isoform II (GST-II-27). These patents provide genomic DNA sequences encoding the gene promoter for the GST-II-27 subunit. By linking this promoter to an exogenous gene and introducing it into a plant through transformation, Holt's work allows for external regulation of gene expression. This transformation can lead to the production of herbicide-resistant transgenic plants, showcasing the potential for enhanced agricultural practices.
Career Highlights
David Charles Holt is associated with Zeneca Limited, where he has been instrumental in advancing biotechnological research. His expertise in enzyme technology and genetic engineering has positioned him as a key figure in the field. His contributions have not only expanded the understanding of plant genetics but have also paved the way for practical applications in agriculture.
Collaborations
Holt has collaborated with notable colleagues, including Ian George Bridges and Simon W Bright. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the realm of biotechnology.
Conclusion
David Charles Holt's work exemplifies the intersection of innovation and practical application in biotechnology. His patents and collaborations reflect a commitment to advancing agricultural technology through scientific research. His contributions continue to influence the field and hold promise for future developments in transgenic plants.